Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macrophage polarization (M2 to M1) describes the process by which macrophages switch from an anti-inflammatory, tissue-repairing (M2) phenotype to a pro-inflammatory, microbicidal (M1) phenotype. This transition is driven by environmental cues like IFNγ, LPS, and TNF, and involves complex signaling pathways, altered gene expression, and changes in cytokine production. Repolarizing tumor-associated macrophages (TAMs) from M2 to M1 is a therapeutic strategy in cancer immunotherapy to enhance anti-tumor immunity.
Repolarization is achieved by modulating signaling pathways like JAK-STAT and NF-kB, leading to altered gene expression and cytokine production.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage Polarization (M2 to M1) (M2 to M1 Polarization).